Drug intelligence / Profile preview

Qingfei Sanjie

Development stage: Preclinical
Lead developer: Guangdong Provincial Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

Qingfei Sanjie is a Traditional Chinese Medicine (TCM) herbal formula developed by the Guangdong Provincial Hospital of Traditional Chinese Medicine for the treatment of pulmonary nodules, specifically those classified as Lung-RADS 2-3. Based on TCM principles of clearing heat from the lungs (Qingfei) and dissipating masses or nodules (Sanjie), the formula is intended to reduce nodule size and prevent malignant transformation. It is currently being evaluated in randomized controlled clinical trials to establish its efficacy and safety profile as a non-invasive therapeutic option for patients with stable or low-risk pulmonary nodules.

Brand names: Qingfei Sanjie decoction
Other names: Qingfei Sanjie formulaQingfei Sanjie decoction

Beyond the preview

Go deeper on Qingfei Sanjie.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingfei Sanjie.

Explore the full profile